CK Life Sciences Int’l., (Holdings) Inc. (Stock Code: 0775) has released updated information on its Board of Directors. The Board is composed of six Executive Directors and five Non-executive Directors, with Executive Director Li Tzar Kuoi, Victor serving as Chairman. Other Executive Directors include Kam Hing Lam as President, Ip Tak Chuen, Edmond as Senior Vice President and Chief Investment Officer, Yu Ying Choi, Alan Abel as Deputy Chairman, Lance Richard Lee Yuen as Vice President and Chief Executive Officer, and Toh Kean Meng, Melvin as Vice President and Chief Scientific Officer.

Non-executive Directors include Peter Peace Tulloch, along with four Independent Non-executive Directors: Kwok Eva Lee, Kwan Kai Cheong, Paul Joseph Tighe, and Donald Jeffrey Roberts. The company also disclosed five Board committees, covering areas such as audit, remuneration, nomination, sustainability, and executive management. According to the announcement, Li Tzar Kuoi, Victor holds chairmanship of the Nomination Committee, while Kwok Eva Lee chairs the Audit Committee and Kwan Kai Cheong oversees the Remuneration Committee. Paul Joseph Tighe leads both the Sustainability and Executive Committees alongside other key personnel. The updated roles and responsibilities take effect as of 1 November 2025.